Cordeiro Bruna Mascaro, Oliveira Indhira Dias, Alves Maria Teresa de Seixas, Saba-Silva Nasjla, Capellano Andrea M, Cavalheiro Sergio, Dastoli Patrícia, Toledo Silvia Regina Caminada
Pediatric Oncology Institute/GRAACC, Department of Pediatrics, Federal University of São Paulo, São Paulo, SP, Brazil,
Childs Nerv Syst. 2014 Jul;30(7):1165-72. doi: 10.1007/s00381-014-2403-x. Epub 2014 Apr 3.
Infant medulloblastoma (MB) is a malignant neuroepithelial embryonal tumor of the cerebellum, believed to derive from precursor granule cells with stem or progenitor cells appearance, and caused by a change in expression profile of genes related to the development. This work aims to study the expression profile of these genes in MB tumors, correlating with clinicopathological characteristics.
We quantified, by qPCR in 40 MB tumor samples, the expression of genes in HH (PTCH1, PTCH2, and GLI1), WNT (APC, CTNNB1, WIF1, and DKK2), and NOTCH pathways (NOTCH2 and HES1), which have a crucial role in development, and genes as MYCC, MYCN, and TERT, correlating this findings to patient's clinicopathological characteristics.
Considering the universal RNA as our control sample, and considering the median of gene expression in the control samples as our cutoff, we observed that HES1 gene showed decreased expression compared to control (p = 0.0059), but patients with HES1 overexpression were directly related to a shorter survival (p = 0.0165). Individuals with higher GLI1 gene expression had significant shorter survival (p = 0.0469), and high expression was prevalent in patients up to 5 years old (p = 0.0479). Patients showing high PTCH2 expression were related to worse survival (p = 0.0426), and it was correlated with GLI1 high expression (p = 0.0094). We also observed a concomitant overexpression of WIF1 and DKK2 genes in a subgroup of MB samples (n = 11, p = 0.0118).
Our results suggest the presence of activated developmental signaling pathways in MB, which are important for cell proliferation and maintenance, and that may be targeted for novel therapeutic options.
婴儿髓母细胞瘤(MB)是一种小脑恶性神经上皮胚胎性肿瘤,被认为起源于具有干细胞或祖细胞外观的前体颗粒细胞,由与发育相关基因的表达谱改变引起。本研究旨在探讨这些基因在MB肿瘤中的表达谱,并与临床病理特征相关联。
我们通过qPCR对40例MB肿瘤样本中HH(PTCH1、PTCH2和GLI1)、WNT(APC、CTNNB1、WIF1和DKK2)以及NOTCH通路(NOTCH2和HES1)中在发育过程中起关键作用的基因,以及MYCC、MYCN和TERT基因进行定量,并将这些结果与患者的临床病理特征相关联。
以通用RNA作为对照样本,并将对照样本中基因表达的中位数作为截断值,我们观察到HES1基因表达与对照相比降低(p = 0.0059),但HES1过表达的患者生存时间直接缩短(p = 0.0165)。GLI1基因表达较高的个体生存时间显著缩短(p = 0.0469),且高表达在5岁以下患者中更为普遍(p = 0.0479)。PTCH2高表达的患者生存情况较差(p = 0.0426),且与GLI1高表达相关(p = 0.0094)。我们还在一组MB样本(n = 11,p = 0.0118)中观察到WIF1和DKK2基因的同时过表达。
我们的结果表明MB中存在激活的发育信号通路,这些通路对细胞增殖和维持很重要,可能成为新的治疗靶点。